Cargando…

Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study

Detalles Bibliográficos
Autores principales:	Ishibashi, Yoshiki, Nishitani, Rie, Shimura, Akiyoshi, Takeuchi, Ayano, Touko, Mamoru, Kato, Takashi, Chiba, Sahoko, Ashidate, Keiko, Ishiwata, Nobuo, Ichijo, Tomoyasu, Sasabe, Masataka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550425/ https://www.ncbi.nlm.nih.gov/pubmed/34705891 http://dx.doi.org/10.1371/journal.pone.0259430

Ejemplares similares

Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
por: Ishibashi, Yoshiki, et al.
Publicado: (2020)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Suvorexant, a Dual Orexin Receptor Antagonist, Protected Seizure through Interaction with GABA(A) and Glutamate Receptors
por: Razavi, Bibi Marjan, et al.
Publicado: (2020)

PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

PT653. Experience using suvorexant to treat delirium
por: Fujiwara, Kodo, et al.
Publicado: (2016)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

Effect of Suvorexant on Nocturnal Delirium in Elderly Patients with Alzheimer’s Disease: A Case-series Study
por: Hanazawa, Tomoki, et al.
Publicado: (2019)

Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021)

A Longitudinal Study of Subjective Daytime Sleepiness Changes in Elementary School Children Following a Temporary School Closure Due to COVID-19
por: Komada, Yoko, et al.
Publicado: (2021)

Remote Work Decreases Psychological and Physical Stress Responses, but Full-Remote Work Increases Presenteeism
por: Shimura, Akiyoshi, et al.
Publicado: (2021)

Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
por: McGaughey, Georgia, et al.
Publicado: (2014)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Identification of the simultaneous use of multiple hypnotics as a risk factor for falls in hospitalized patients by a matched case-control study
por: Morishita, Chihiro, et al.
Publicado: (2023)

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
por: Toi, Norikazu, et al.
Publicado: (2018)

Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
por: Tamura, Kiyoshi, et al.
Publicado: (2018)

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium
por: Nazeer, Sahana, et al.
Publicado: (2023)

Quantification of Suvorexant in Human Urine Using a Validated HPTLC Bioanalytical Method
por: Alqarni, Mohammed H., et al.
Publicado: (2023)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

PT666. Check an effeciency About the Suvorexant with Combining Other Sleep Promoting Medicines
por: Akira Iwanami, Toshiaka Tsuneoka, et al.
Publicado: (2016)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

2420 Examining characteristics of placebo effects on trauma-related insomnia in a suvorexant trial
por: Uweh, Kimberly
Publicado: (2018)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2015)

Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial
por: Azuma, Kazunari, et al.
Publicado: (2018)

Suvorexant (Belsomra(®) Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
por: Asai, Yuko, et al.
Publicado: (2018)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023)

On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly
por: Vermeeren, Annemiek, et al.
Publicado: (2016)

Alternative use of suvorexant (Belsomra(®)) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
por: Flores-Ramirez, Francisco J., et al.
Publicado: (2022)

A case of bilateral tubal pregnancy
por: Funamizu, Ayano, et al.
Publicado: (2017)

Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
por: Takenaka, Kenchi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9en8o71i5fvm62sk1aebfevdq6